AZTR
Price
$0.32
Change
+$0.01 (+3.23%)
Updated
Apr 25 closing price
Capitalization
4.76M
10 days until earnings call
MMIRF
Price
$0.02
Change
-$0.05 (-71.43%)
Updated
Apr 9 closing price
Capitalization
45.51M
Ad is loading...

AZTR vs MMIRF

Header iconAZTR vs MMIRF Comparison
Open Charts AZTR vs MMIRFBanner chart's image
Azitra
Price$0.32
Change+$0.01 (+3.23%)
Volume$43.43M
Capitalization4.76M
Medmira
Price$0.02
Change-$0.05 (-71.43%)
Volume$1K
Capitalization45.51M
AZTR vs MMIRF Comparison Chart
Loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTR vs. MMIRF commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTR is a Buy and MMIRF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (AZTR: $0.32 vs. MMIRF: $0.02)
Brand notoriety: AZTR and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AZTR: 2704% vs. MMIRF: 17%
Market capitalization -- AZTR: $4.76M vs. MMIRF: $45.51M
AZTR [@Biotechnology] is valued at $4.76M. MMIRF’s [@Biotechnology] market capitalization is $45.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTR’s FA Score shows that 0 FA rating(s) are green whileMMIRF’s FA Score has 0 green FA rating(s).

  • AZTR’s FA Score: 0 green, 5 red.
  • MMIRF’s FA Score: 0 green, 5 red.
According to our system of comparison, both AZTR and MMIRF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTR’s TA Score shows that 5 TA indicator(s) are bullish.

  • AZTR’s TA Score: 5 bullish, 5 bearish.

Price Growth

AZTR (@Biotechnology) experienced а +11.51% price change this week, while MMIRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

AZTR is expected to report earnings on May 08, 2025.

MMIRF is expected to report earnings on Apr 02, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMIRF($45.5M) has a higher market cap than AZTR($4.76M). MMIRF YTD gains are higher at: 58.015 vs. AZTR (-25.311). MMIRF has higher annual earnings (EBITDA): -3.13M vs. AZTR (-8.5M). AZTR has more cash in the bank: 4.56M vs. MMIRF (296K). AZTR has less debt than MMIRF: AZTR (556K) vs MMIRF (9.49M). MMIRF has higher revenues than AZTR: MMIRF (277K) vs AZTR (7.5K).
AZTRMMIRFAZTR / MMIRF
Capitalization4.76M45.5M10%
EBITDA-8.5M-3.13M271%
Gain YTD-25.31158.015-44%
P/E Ratio0.00N/A-
Revenue7.5K277K3%
Total Cash4.56M296K1,539%
Total Debt556K9.49M6%
FUNDAMENTALS RATINGS
MMIRF: Fundamental Ratings
MMIRF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTR
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMIX20.74-0.03
-0.14%
Macquarie Emerging Markets Instl
IGHAX12.32-0.02
-0.16%
Voya Global High Dividend Low Vol Port A
DFRSX16.94-0.04
-0.24%
DFA Asia Pacific Small Company I
MXMDX19.11-0.08
-0.42%
Empower S&P Mid Cap 400® Index Inv
NIOAX13.25-0.09
-0.67%
Neuberger Berman Intl Small Cap A

AZTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTR has been closely correlated with DARE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTR jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTR
1D Price
Change %
AZTR100%
+3.86%
DARE - AZTR
73%
Closely correlated
-0.50%
SLRX - AZTR
39%
Loosely correlated
+1.84%
SAGE - AZTR
33%
Poorly correlated
N/A
SNTI - AZTR
31%
Poorly correlated
+2.67%
KNSA - AZTR
26%
Poorly correlated
+3.92%
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
-5.76%
AZTR - MMIRF
24%
Poorly correlated
+3.86%
SRPT - MMIRF
22%
Poorly correlated
-2.14%
SAGE - MMIRF
22%
Poorly correlated
N/A
More